| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2025―Feb―03 |
Identification of Common Pathogenetic Processes between Epilepsy and Coronavirus Disease-19 by Weighted Gene Co-Expression Network Analysis |
Zihui Yu, Ziying Xu, Shang Li, Ziyan Tian, Fuping You, Jing Yuan |
| 2 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2025―Feb―03 |
Treatment of Coronavirus Disease-19 using Thymoquinone |
T. A. Alamri |
| 3 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2024―Jul―03 |
Evaluation of the Real-World Effectiveness of Traditional Chinese Medicine in Treating Coronavirus Disease-2019 |
Yajie Liu, Rumei Xiang, Jinliang Yang, Jiaheng Shi, Yaoyue Hu, Lianguo Ruan, et al. (+10) Tao Bai, Jiaqi Chai, Xinghua Xiang, Mimi Xiao, Jingyu Zhang, Wei Xu, Hui Zhao, Jie Liu, Yang Yang, Qiuling Shi |
| 4 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2024―Feb―21 |
In Silico Analysis of Siddha Formulation Thippili Rasayanam Against COVID-19 in Inhibition of Ribonucleic Acid-Dependent Ribonucleic Acid Polymerase Target Enzyme |
S. M. Chitra |
| 5 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Dec―07 |
Efficacy and Direct Medical Costs of Metformin-Glibenclamide Treatment in Ecuadorian Population with Type II Diabetes Mellitus during the COVID-19 Pandemic |
R. Zambrano, Maria Del Carmen Cabezas, G. Loor, Nicole Aguirre, Camila Mino |
| 6 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Sep―11 |
Development and Validation of Favipiravir Severe Acute Respiratory Syndrome Coronavirus 2 Drug by Dissolution Method with Filter Compatibility Study |
S. Kanithi, N. S. S. P. K. Chebolu, G. N. Challa |
| 7 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Mar―17 |
Immunological Response to Conventional COVID-19 Vaccines in a Cohort of Pakistani Healthy Recipients |
Rajaa Mohammad Al-Raddadi, A. Rehman, Sadia Farhad, T. A. Khan, Sumera Sumera, A. M. Hashem, et al. (+8) E. I. Azhar, M. Almuhayawi, T. S. Abujamel, Jawahir Ahmad Mokhtar, H. A. Niyazi, T. Alamri, S. Harakeh, Y. M. Yousafzai |
| 8 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Feb―27 |
Molecular Docking study of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein with Celastroid Triterpenoid Inhibitors |
Bhaskar Bagchi, Tamal Goswami |
| 9 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Jan―27 |
Potential Mechanism of Colchicine against COVID-19 and Non-Small Cell Lung Cancer based on Network Pharmacology and Bioinformatics Analysis |
Zhiyao Liu, Hailiang Huang, Ying Yu, Yuqi Jia, Lingling Li, Xin Shi, Fangqi Wang |
| 10 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Jan―27 |
Retrospective Analysis of Neutralizing Antibody Cocktail (Casirivimab and Imdevimab): A Game Changer in Treating Mild COVID-19 Patients |
Anu Gaikwad, Vini Mehta, Chirali Shah, Mansi Agrawal, R. A. Shaik, Mashael B. Alharbi, et al. (+11) M. Alrouji, S. Alhajlah, O. Alomeir, Ritu Kumar Ahmad, M. S. Ahmad, F. H. Alanazi, A. Alharbi, A. Tawakul, M. T. Hemdi, K. K. Aldossari, R. Aldahash |
| 11 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Jan―05 |
An Overview of the Approaches for the Pharmacotherapy of Pandemic Causing Coronaviruses of the 21st Century |
Prachi Prajapati, S. Singh, K. R. Iyer |
| 12 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Nov―16 |
Plasma Therapy: An Effective Treatment for Infections from Microbes with Special Reference to Coronavirus Disease 2019 |
Shivani Sainani, D. Bhombe, Ketki Rode, A. Deshmukh, Shivani Desai |
| 13 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Nov―16 |
Inhibitory Potentials of Phytoconstituents of Phyllanthus amarus against Severe Acute Respiratory Syndrome-Corona Virus-2 Main Protease: A Computational Aided Approach |
M. Pushpa Sree, G. Prakash Yoganandam, V. Gopal |
| 14 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Jul―13 |
Phytochemicals: A Novel Approach for the Management of Coronavirus Disease 2019 |
R. S. Shivatare, R. Musale, N. K. Bhutale, S. M. Kewatkar, H. L. Tare, Vibhavari Chatur, et al. (+2) A. N. Khatawakar, D. S. Suryavanshi |
| 15 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Jul―13 |
An Integrated Strategy Designed To Explore the Common and Diverging Mechanisms of Potential Drugs against the Novel Coronavirus Pneumonia Based on Network Pharmacology and In Silico Molecular Docking Technology |
Q. Zhao, G. H. Li, B. Zheng, P. Feng, P. Wang, X. Li |
| 16 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Mar―18 |
The Effect of Ivermectin on Reducing Viral Symptoms in Patients with Mild COVID-19 |
K. U. Abbas, S. Muhammad, S. F. Ding |
| 17 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Mar―18 |
Convalescent Plasma Therapy: A Treatment of Choice for COVID-19 during Current Pandemic |
T. M. Yunus Khan, I. A. Badruddin, S. A. Saquib, R. Mohamed, S. Arora, M. A. K. Mohammed, et al. (+5) S. V. Shamsuddin, S. Khateeb, A. A. Khan, V. Grover, Priyanka Saluja |
| 18 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Mar―18 |
Attitudes and Belief among the Population in Saudi Arabia about the Consumption of Herbal Products for the Prevention of COVID-19 Infection: A Cross-Sectional Study |
Afaf Aldahish, Mona Almanasef, Nouf Al-Saad, Reem Asiri, Rajalakshimi Vasudevan, Geetha Kandasamy |
| 19 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Mar―07 |
Virtual Screening of Anti Severe Acute Respiratory Syndrome Coronavirus 2 Drugs Targeting Main Protease |
Hui Mao, Chunxia Chu, Xianyue Hu, Yue Yuan |
| 20 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Dec―17 |
The Preparedness of Emergency Medical Services Students for Coronavirus Disease 2019: A Cross-Sectional Study among Paramedic Students |
D. M. Al Razeeni, A. Al-Wathinani, R. Alhazmi, O. A. Samarkandi, S. A. Ronal, Basma Salameh, A. Alenazi |
| 21 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Dec―07 |
Potential of Bacteriophage Therapy: A Double Edge Sword to Combat COVID-19 and Associated Pulmonary Bacterial Infections |
Kanika Bhargava, G. Nath, G. K. Aseri, Neelam Jain |
| 22 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Dec―07 |
Identification of Compounds from Curcuma longa with In Silico Binding Potential against SARS-CoV-2 and Human Host Proteins Involve in Virus Entry and Pathogenesis |
S. Kumar, A. K. Singh, P. P. Kushwaha, Kumari Sunita Prajapati, S. Senapati, S. Mohd Mohd, S. Gupta |
| 23 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Nov―09 |
Insights into Molecular Mechanisms Underlying COVID-19 Pathogenesis and Potential Therapeutics |
Shravanthi Ravula, Sai Charitha Mullaguri, Sravani Akula, R. Silveri, R. K. Kancha |
| 24 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Aug―04 |
Clinical Characteristics of Nutritional Indicators in Patients with Covid-19 |
Bo Yuan Zhang, Y. T. Sun, H. Pan, Li Zhang |
| 25 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Jul―03 |
In silico Studies Predict Efficient Binding of Remdesivir and Favipiravir with 3-chymotrypsin like protease of SARS-CoV-2 for COVID-19 Interventional Therapy |
D. Dey, N. Dey, Shalini Ghosh, Padma Thiagarajan |
| 26 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―May―14 |
Discussion on the Correlation between Clinical Typing of Covid-19 Patients and Risk Factors and Peripheral Red Blood Cell Parameters |
LI ZHANG, L. X. WANG, J. Y. ZHAO, Y. S. WANG, Y. T. SUN |
| 27 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―May―14 |
Construction of Novel Coronavirus Pneumonia Emergency Management System Based on Multi Agent Cooperation Mechanism |
J. F. SHANG |
| 28 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―May―11 |
In silico Multi Subunit Vaccine Design Referring Spike Glycoprotein of SARS-COV-2 (COVID-19): The World Pandemic |
ANKUR BHARDWAJ |
| 29 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―May―11 |
The Difficulties, Opportunities and Challenges of Covid-19 by Chinese Medicine on China |
XUANXUAN WANG, HUA LI, PING WANG, XUN GONG, GUANGJIE LI, ZHENCHUAN JIANG, et al. (+5) JIAO CHEN, GUO LU, HONGPING CHENG, ZHENG WANG, XIAOWEI. WU |
